Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.
The Clinical Respiratory Journal|January 25, 2019
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidoneSergio Harari, Antonella Caminati, Marco Confalonieri, et al.
ERJ Open Research|November 26, 2025
How do climate conditions and urbanisation impact nontuberculous mycobacterial infections? An Italian nationwide case-control studyPaola Faverio, Lorenzo Del Castello, Maura Spotti, et al.
Clinical and Experimental Rheumatology|January 31, 2017
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based studyOlga Addimanda, Massimiliano Marino, Ilaria Farina, et al.
Clinical and Experimental Rheumatology|April 3, 2026
Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational studyCaterina Vacchi, Marco Sebastiani, Antonio Carletto, et al.
ERJ Open Research|March 19, 2024
Diagnostic delay in bronchiectasis: an Italian perspectiveCarlo Chessari, Edoardo Simonetta, Francesco Amati, et al.
Respiratory Research|September 3, 2022
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approachPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2024
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome ProjectSara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, et al.
Journal of Autoimmunity|August 10, 2015
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre studyLuca Quartuccio, Francesca Zuliani, Laura Corazza, et al.
Autoimmunity Reviews|July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registryFabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.
Pageof 27